Theodor Dingermann
Corporate Officer/Principal chez Johann Wolfgang Goethe-Universität Frankfurt am Main
Profil
Theodor Dingermann is currently the Head of the Pharmaceutical Biology Institute at Johann Wolfgang Goethe-Universität Frankfurt am Main.
Previously, he served as the Director of the Executive Board at Protagen AG from 2009 to 2010.
Postes actifs de Theodor Dingermann
| Sociétés | Poste | Début |
|---|---|---|
| Johann Wolfgang Goethe-Universität Frankfurt am Main | Corporate Officer/Principal | 21/08/2009 |
Anciens postes connus de Theodor Dingermann
| Sociétés | Poste | Fin |
|---|---|---|
Protagen AG
 Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Protagen AG
Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Health Technology |